Chemoinformaics analysis of 2,2-DIMETHYL-3-[(2E)-3-METHYLPENTA-2,4-DIENYL]OXIRANE
Molecular Weight | 152.237 | nRot | 3 |
Heavy Atom Molecular Weight | 136.109 | nRig | 18 |
Exact Molecular Weight | 152.12 | nRing | 1 |
Solubility: LogS | -4.769 | nHRing | 1 |
Solubility: LogP | 4.452 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 0 | BPOL | 17.7873 |
QED | 0.826 |
Synth | 4.482 |
Natural Product Likeliness | 1.598 |
NR-PPAR-gamma | 0.846 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.778 |
Pgp-sub | 0.041 |
HIA | 0.024 |
CACO-2 | -4.852 |
MDCK | 0.0000232 |
BBB | 0.225 |
PPB | 0.96065 |
VDSS | 1.173 |
FU | 0.0401932 |
CYP1A2-inh | 0.103 |
CYP1A2-sub | 0.795 |
CYP2c19-inh | 0.462 |
CYP2c19-sub | 0.884 |
CYP2c9-inh | 0.455 |
CYP2c9-sub | 0.781 |
CYP2d6-inh | 0.04 |
CYP2d6-sub | 0.872 |
CYP3a4-inh | 0.239 |
CYP3a4-sub | 0.531 |
CL | 12.393 |
T12 | 0.406 |
hERG | 0.013 |
Ames | 0.28 |
ROA | 0.78 |
SkinSen | 0.539 |
Carcinogencity | 0.718 |
EI | 0.134 |
Respiratory | 0.979 |
NR-Aromatase | 0.927 |
Antiviral | No |
Prediction | 0.918841 |